Information Provided By: 
Fly News Breaks for May 6, 2016
ZTS
May 6, 2016 | 05:36 EDT
Goldman Sachs analyst Jami Rubin downgraded Zoetis to Sell saying the shares are fairly valued at current levels. The company's fundamentals are sound, but peers offer more share upside, Rubin tells investors in a research note. The analyst has a $48 price target for the shares. Zoetis closed yesterday up $1.20 to $48.25.
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
